Vancocin Italia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VANCOCIN ITALIA, and what generic alternatives to VANCOCIN ITALIA drugs are available?
VANCOCIN ITALIA has one approved drug.
There are four US patents protecting VANCOCIN ITALIA drugs.
There are fifty-two patent family members on VANCOCIN ITALIA drugs in twenty countries and eleven supplementary protection certificates in ten countries.
Drugs and US Patents for Vancocin Italia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 8,530,668 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 9,427,402 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 8,889,722 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 7,601,746 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Vancocin Italia Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2599529 | ⤷ Try a Trial |
Poland | 2184279 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2012043709 | ⤷ Try a Trial |
European Patent Office | 2184279 | ⤷ Try a Trial |
China | 103228277 | ⤷ Try a Trial |
Taiwan | 200914000 | ⤷ Try a Trial |
Taiwan | 200517387 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vancocin Italia Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2184279 | 1990035-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG; REG. NO/DATE: EU/1/18/1348 20190220 |
2184279 | 132019000000090 | Italy | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG(LUSUTROMBOPAG SHIONOGI); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1348, 20190220 |
2184279 | CA 2019 00038 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG OG FARMACEUTISK ACCEPTABLE SALTE ELLER SOLVATER DERAF; REG. NO/DATE: EU/1/18/1348 20190220 |
2184279 | SPC/GB19/049 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTERED: UK EU/1/18/1348(FOR NI) 20190220; UK PLGB 50999/0007 20190220 |
2184279 | 2019/039 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE THEREOF.; REGISTRATION NO/DATE: EU/1/18/1348 20190218 |
2184279 | 122019000065 | Germany | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG; REGISTRATION NO/DATE: EU/1/18/1348 20190218 |
2184279 | 2019C/534 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT HIERVAN; AUTHORISATION NUMBER AND DATE: EU/1/18/1348 20190220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.